Insiders Roche Holding AG

Equities

Market Closed - Swiss Exchange Other stock markets 11:31:35 2024-06-07 am EDT			5-day change	1st Jan Change
242.6 ^CHF	+1.89%		+6.26%	-0.78%

Jun. 07	Roche: efficacy of Evrysdi in spinal muscular atrophy	CF
Jun. 07	Roche's Five-year Data Confirms Efficacy, Safety of Evrysdi Drug for Spinal Muscular Atrophy in Children	MT

Roche appoints Director of Corporate Business Development	May. 27	CF
Roche Announces Management and Board Committee Changes	May. 27	CI
Roche Expects Sales, Core Earnings Growth -- Update	Feb. 01	DJ
Roche Expects Sales, Core Earnings Growth	Feb. 01	DJ
Roche Named Third Most Sustainable Company on Dow Jones' Pharmaceuticals Index	Dec. 15	MT
Bayer's new CEO plans to cut management jobs in prelude to overhaul	23-09-15	RE
Bayer's new CEO plans to cut management jobs in prelude to overhaul	23-09-14	RE
Destiny Pharma picks interim CEO as Clark makes quick exit	23-05-25	AN
Roche Q1 sales down 7% as COVID-related business wanes	23-04-26	RE
Roche Holding AG Approves Board and Board Committee Changes	23-03-14	CI
Johnson & Johnson names ex-Sanofi executive as pharma, R&D vice president	23-02-13	RE
Bayer's new CEO: long-time Roche, Genentech executive, Bill Anderson	23-02-08	RE
Bayer Taps Roche's Bill Anderson as New CEO; Succession Due in Coming Months	23-02-08	DJ
Bayer picks outsider Anderson as CEO after investor pressure	23-02-08	RE
Bayer Appoints Former Roche Executive as CEO	23-02-08	MT
Roche Names CEO for Pharmaceuticals Unit	23-02-02	MT
Roche flags 2023 earnings decline on slump in COVID products	23-02-02	RE
Roche Holding AG Announces Executive Appointments	23-02-02	CI
Roche Seeks Internal Candidate To Succeed Pharmaceutical Unit's CEO	23-01-11	MT
Roche names new CEO with Schwan set to become chairman	22-12-12	RE

No results for this search

ROCHE HOLDING : In line quarterly results won’t cut it for Roche

April 24, 2024 at 11:50 am EDT

Obesity: Roche joins the battle

December 04, 2023 at 10:48 am EST